Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-20 Option Award | 2026-01-22 5:48 pm | N/A 2036-01-20 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Executive Officer | 1,165,000 | $0 | 1,165,000 (Direct) | View |
| 2024-01-12 Option Award | 2025-02-11 5:52 pm | N/A 2034-01-12 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Executive Officer | 960,000 | $0 | 960,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:08 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Executive Officer | 1,121,300 | $0 | 1,121,300 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 5:16 pm | N/A 2033-02-01 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin See Remarks | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 4:30 pm | N/A 2032-07-24 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin See Remarks | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 4:26 pm | N/A 2032-01-17 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Scientific Officer | 140,000 | $0 | 140,000 (Direct) | View |